This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Nosocomial condition (hospital)
VWXY20_SAIRAALO_LIITTYVAT_TAPATURMAT
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
203 |
4. Check minimum number of eventsNone |
203 |
5. Include endpointsNone |
203 |
6. Filter based on genotype QC (FinnGen only) |
203 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Y9[4-6]
Similar endpoints
↥List of similar endpoints to
Nosocomial condition (hospital)
based on the number of shared cases.
Similar with more cases:
- Type of accident
- Supplementary factors related to causes of morbidity and mortality classified elsewhere
- External causes of morbidity and mortality
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 203 | 109 | 94 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | 70.72 | 71.59 | 69.72 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 178
- Matched controls
- 1780
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Y95.0
ICD-10 Finland
Accident in a hospital or hospital associated external cause
+∞
220.9
163
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
4.2
17.9
97
395
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
5.9
16.0
48
104
Y95
ICD-10 Finland
Nosocomial condition
+∞
15.9
15
*
T81.9
ICD-10 Finland
Unspecified complication of procedure
37.3
13.8
17
5
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
3.7
9.5
44
144
SPAT1254
SPAT
Administration of medicine
3.3
9.4
54
207
N02BE01
ATC
paracetamol; systemic, rectal
4.1
9.3
162
1263
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
12.4
9.3
16
14
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
5.3
9.2
28
60
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
3.4
9.0
49
181
N02AA05
ATC
oxycodone; systemic
3.5
8.9
44
151
A28
ICPC
Limited function/disability NOS
3.3
8.8
51
195
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.9
8.8
29
68
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.2
8.6
51
200
X59
ICD-10 Finland
Exposure to unspecified factor
3.2
8.6
51
200
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
7.7
8.5
19
27
C03CA01
ATC
furosemide; systemic
2.6
8.5
82
434
AA1AD
NOMESCO Finland
CT of head and brain
2.8
8.4
65
300
R5140
SPAT
NA
+∞
8.4
8
*
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
5.2
8.2
25
54
SPAT1301
SPAT
No procedures
2.6
8.0
73
370
F20.9
ICD-10 Finland
Schizophrenia, unspecified
13.9
8.0
13
10
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
5.5
7.9
23
47
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
4.7
7.7
26
63
X58
ICD-10 Finland
Exposure to other specified factors
3.5
7.7
37
124
UKC02
NOMESCO Finland
Cystoscopy
3.1
7.6
45
175
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.0
7.4
47
189
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.1
7.2
43
166
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.5
7.1
66
335
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
8.1
7.1
15
20
Y94.0
ICD-10 Finland
Accident at home
8.8
7.0
14
17
B01AB05
ATC
enoxaparin; parenteral
2.5
6.8
65
336
L28
ICPC
Limited function/disability (L)
2.8
6.7
47
202
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
12.9
6.7
11
9
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.8
6.6
21
48
S01.0
ICD-10 Finland
Open wound of scalp
3.9
6.6
26
74
N03AX09
ATC
lamotrigine; oral
7.0
6.5
15
23
SPAT1216
SPAT
Assessment of functional ability
2.7
6.4
46
201
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.7
6.4
46
201
SPAT1215
SPAT
Assessment of need for medical rehabilitation
5.4
6.4
18
36
R39.1
ICD-10 Finland
Other difficulties with micturition
7.5
6.4
14
20
SPAT1234
SPAT
Support of social functional capacity
5.1
6.3
19
41
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
27.8
6.3
8
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.4
6.3
62
323
N05AH02
ATC
clozapine; systemic
8.2
6.2
13
17
H02AB06
ATC
prednisolone; systemic
2.2
6.2
90
560
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
6.2
49
226
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
150
772
4.61
22.03
10.3
6.0
1.21
1.22
mmol/l
0.46
129
650
127
622
3.78
19.07
2.9
2.3
73.53
76.00
nmol/l
0.38
114
536
41
88
5.59
18.96
5.6
3.2
0.18
0.09
e6/l
0.68
41
88
42
99
5.09
17.41
5.4
2.8
1.53
1.94
mmol/l
0.32
31
70
170
1064
4.68
16.67
8.6
5.0
10250.00
2674.21
e6/l
0.62
11
24
144
808
3.69
16.64
8.0
5.8
16.07
11.12
umol/l
0.70
133
769
133
722
3.44
15.96
7.8
5.3
1.20
1.22
mmol/l
1.09
119
645
128
680
3.39
15.91
6.4
4.1
33.05
35.09
g/l
3.35
112
627
68
246
3.65
15.80
2.8
2.1
9.23
13.19
umol/l
3.24
60
221
128
691
3.31
15.27
5.8
4.0
—
—
—
0
0
91
417
3.14
14.15
2.8
2.0
3.14
3.32
mg/l
0.20
77
352
119
636
3.11
14.07
5.6
4.0
43.49
46.18
ng/l
0.08
93
463
79
336
3.21
13.92
2.1
1.7
1247.07
1158.78
nmol/l
0.33
64
252
58
206
3.54
13.66
2.9
2.2
15.92
22.51
%
2.55
42
178
61
227
3.41
13.32
3.0
2.1
2.33
2.33
g/l
0.02
56
204
173
1193
4.05
12.53
11.3
7.1
91.94
77.15
u/l
1.38
163
1104
119
666
2.90
12.44
3.8
2.6
134.55
120.31
ug/l
0.36
108
598
124
711
2.91
12.35
10.5
5.7
23.87
26.49
%
1.80
119
662
65
262
3.18
12.35
1.8
1.8
—
—
—
0
0
97
489
2.88
12.32
5.0
2.2
50.19
56.06
u/l
1.08
91
455
55
201
3.38
12.27
5.2
4.1
1.06
1.03
mmol/l
0.26
49
180
97
497
2.82
11.84
4.0
3.3
2739.71
1618.99
ng/l
0.56
82
416
121
702
2.79
11.50
10.2
5.5
61.07
58.79
%
1.22
116
654
161
1127
3.07
10.00
5.6
4.1
17.04
12.95
mm/h
2.41
146
1024
135
868
2.66
9.84
16.5
9.1
4.58
4.29
e9/l
0.66
125
764
48
185
3.09
9.63
6.6
5.9
1.89
1.36
mmol/l
0.44
38
144
192
1519
5.87
9.40
35.6
15.0
25.63
24.05
mg/l
0.31
181
1198
38
131
3.34
9.14
2.0
1.5
—
—
—
0
0
42
156
3.13
8.93
3.8
4.3
4.54
51.87
ug/l
0.59
31
135
20
44
4.93
8.80
2.3
2.1
113.22
127.63
g/l
1.03
20
30
94
530
2.44
8.79
3.6
3.3
2.32
2.35
mmol/l
1.63
78
447
38
137
3.18
8.48
2.1
2.1
0.18
0.21
g/l
1.36
32
125
18
39
4.97
8.05
1.9
1.4
—
—
—
0
0
32
107
3.36
8.04
6.2
5.4
25.89
24.26
mmol/l
1.57
32
98
14
24
6.19
7.97
1.6
1.8
—
—
—
0
0
80
435
2.38
7.95
7.4
4.4
0.00
0.00
estimate
0.00
25
142
29
92
3.51
7.90
1.4
1.5
—
—
—
0
0
48
209
2.70
7.59
1.4
1.3
30.92
17.47
u/ml
0.27
18
82
22
61
3.92
7.25
5.9
3.8
1.92
1.52
%
0.79
22
55
22
61
3.92
7.25
2.1
2.1
—
—
—
0
0
84
482
2.27
7.23
3.9
2.8
33.99
28.85
u/l
0.38
77
457
67
353
2.34
7.02
2.1
1.8
352.71
445.03
pmol/l
2.63
55
287
33
122
3.04
7.01
1.4
3.5
61.52
66.24
g/l
2.31
28
109
97
596
2.20
7.01
4.7
3.1
—
—
—
0
0
34
128
2.99
7.00
5.2
6.0
1.94
1.33
mmol/l
0.50
27
120
30
105
3.18
6.99
2.2
1.4
—
—
—
0
0
72
397
2.26
6.74
2.1
1.5
22.37
21.49
nmol/l
0.15
65
331
13
25
5.49
6.58
1.7
1.6
—
—
—
0
0
36
145
2.80
6.55
8.0
6.7
112.53
120.17
g/l
1.58
36
140
153
1149
2.35
6.46
4.2
3.8
15.22
14.95
pmol/l
0.55
137
1017
102
655
2.12
6.43
2.7
2.0
95.24
94.60
pmol/l
0.04
59
323
188
1566
3.71
6.31
39.8
17.2
138.49
139.59
mmol/l
4.29
183
1506
188
1571
3.66
6.17
39.8
17.3
3.99
3.99
mmol/l
0.01
183
1512
115
782
2.09
6.13
8.3
5.5
0.00
0.00
estimate
0.00
26
147
134
967
2.13
6.06
5.0
3.0
70.71
46.95
u/l
1.49
121
904
96
616
2.06
5.93
7.4
4.3
—
—
—
0
0
20
60
3.59
5.89
1.9
1.9
—
—
—
0
0
115
790
2.05
5.87
6.9
4.1
0.00
0.00
estimate
0.00
27
140
19
56
3.64
5.74
1.7
1.3
—
—
—
0
0
47
230
2.36
5.71
1.2
1.2
23.53
30.85
iu/ml
0.36
16
81
113
781
2.01
5.57
6.8
4.1
0.00
0.00
estimate
0.00
25
151
172
1402
2.49
5.34
5.3
4.6
2.06
1.93
mu/l
0.48
155
1250
39
181
2.43
5.31
1.6
1.7
—
—
—
0
0
17
49
3.70
5.30
2.4
2.7
—
—
—
0
0
38
180
2.37
4.94
1.6
1.6
—
—
—
0
0
193
1686
3.94
4.91
53.8
21.5
259.81
244.19
e9/l
1.81
188
1635
193
1689
3.90
4.83
53.4
21.4
4.14
4.45
e12/l
11.57
188
1631
193
1690
3.88
4.80
53.9
21.6
123.79
133.96
g/l
15.65
188
1650
187
1617
2.99
4.58
16.0
9.9
22.91
24.47
u/l
0.83
179
1547
9
13
7.19
4.21
24.2
11.0
693.78
1008.38
nmol/l
—
9
13
168
1401
2.16
4.21
7.0
5.8
40.37
40.35
mmol/mol
0.01
153
1302
13
38
3.59
3.97
1.5
1.9
—
—
—
0
0
8
11
7.52
3.89
1.9
2.9
—
—
—
0
0
170
1439
2.12
3.86
29.9
14.1
78.50
78.71
ml/min/173m2
0.03
143
1175
11
30
3.82
3.69
1.6
1.1
—
—
—
0
0
47
271
1.96
3.68
4.9
2.8
6.00
2.33
e6/l
0.83
37
153
62
392
1.84
3.67
3.3
2.9
330.11
8809.99
umol/l
2.36
54
334
57
354
1.85
3.56
3.3
2.2
—
—
—
0
0
166
1409
1.98
3.50
4.2
3.8
1.24
1.29
mmol/l
0.38
147
1276
25
115
2.34
3.46
2.9
3.4
76.72
82.20
ng/l
0.19
18
100
169
1467
1.91
3.00
4.8
4.3
4.44
4.55
mmol/l
0.73
150
1343
30
159
2.04
2.95
4.6
3.7
—
—
—
0
0
8
17
4.85
2.95
1.8
1.3
394.41
243.55
u/l
—
8
17
18
77
2.47
2.91
7.9
5.6
22.74
24.73
mmol/l
0.86
18
77
168
1462
1.86
2.87
4.8
4.2
1.48
1.46
mmol/l
0.22
150
1329
27
139
2.09
2.86
1.8
2.5
3.18
7.76
ug/l
1.55
18
124
49
309
1.77
2.86
2.3
1.8
1.48
1.37
mg/l
0.12
43
244
114
897
1.62
2.85
3.0
3.0
—
—
—
0
0
34
193
1.91
2.76
5.3
4.3
35.61
31.08
%
0.79
23
126
51
329
1.73
2.75
1.3
1.3
2.00
1.52
u/ml
0.17
19
93
23
113
2.17
2.74
8.6
3.5
46.62
58.82
ml/min/173m2
0.72
13
50
26
136
2.05
2.65
1.9
3.4
1.52
2.17
mmol/l
0.41
18
103
46
292
1.74
2.62
7.1
3.7
35.75
157.04
ng/l
1.74
36
231
167
1471
1.76
2.47
5.4
4.6
5.93
6.01
mmol/l
0.31
149
1328
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
11
40
2.85
2.41
2.3
2.1
0.26
0.34
u/ml
—
6
18
170
1508
1.78
2.41
5.0
4.7
2.47
2.66
mmol/l
1.73
152
1373
12
46
2.71
2.40
5.5
2.1
1.74
1.59
mg/l
0.21
12
41
5
9
5.66
2.22
1.0
1.0
—
—
—
0
0
11
43
2.65
2.13
4.1
1.6
—
—
—
0
0
7
20
3.59
2.07
1.7
1.8
—
—
—
0
0
10
38
2.72
2.04
2.0
1.6
—
—
—
0
0
7
21
3.41
1.98
1.7
1.8
—
—
—
0
0
7
21
3.41
1.98
1.7
1.8
—
—
—
0
0
7
21
3.41
1.98
1.7
1.8
—
—
—
0
0
7
21
3.41
1.98
1.7
1.8
—
—
—
0
0
7
21
3.41
1.98
1.4
1.8
—
—
—
0
0
5
11
4.63
1.95
1.6
1.6
17.60
11.27
u/l
—
5
11
7
22
3.26
1.89
1.7
1.7
—
—
—
0
0
6
17
3.60
1.85
1.2
1.2
—
—
—
0
0
5
12
4.24
1.83
1.0
1.0
—
—
—
0
0
67
510
1.47
1.74
5.2
4.7
1.65
2.40
ug/l
1.29
60
451
5
13
3.91
1.72
1.2
2.1
—
—
—
0
0
5
13
3.91
1.72
1.2
2.1
—
—
—
0
0
5
13
3.91
1.72
1.2
2.1
—
—
—
0
0
8
31
2.64
1.68
1.1
1.1
—
—
—
0
0
6
19
3.22
1.67
1.5
1.7
—
—
—
0
0
5
14
3.63
1.62
1.2
1.1
—
—
—
0
0
7
26
2.75
1.59
1.6
1.7
—
—
—
0
0
6
20
3.06
1.59
1.5
1.3
8.99
6.75
mmol/l
—
6
12
10
44
2.34
1.56
2.0
2.5
126.80
8290.33
u/l
—
5
12
5
15
3.39
1.53
1.4
1.3
—
—
—
0
0
9
39
2.37
1.45
1.3
1.6
—
—
—
0
0
9
39
2.37
1.45
1.3
1.6
—
—
—
0
0
5
17
2.99
1.36
1.2
1.9
—
—
—
0
0
5
18
2.82
1.29
1.4
1.8
—
—
—
0
0
14
77
1.88
1.29
1.2
1.0
—
—
—
0
0
8
37
2.21
1.23
4.1
1.3
1.09
1.17
g/l
—
8
37
11
57
1.98
1.19
1.0
2.8
—
—
—
0
0
5
21
2.41
1.09
1.4
1.1
—
—
—
0
0
5
22
2.30
1.04
1.4
1.8
—
—
—
0
0
7
35
2.03
1.01
4.6
1.3
0.21
0.22
g/l
—
7
35
0
29
0.00
0.98
0.0
1.8
—
—
—
0
0
57
463
1.32
0.97
3.7
3.0
0.21
0.42
e6/l
1.38
46
354
57
466
1.31
0.92
5.2
3.8
20.02
10.94
mg/mmol
0.52
40
301
39
305
1.34
0.85
4.3
3.2
2.48
2.46
mmol/l
0.41
31
261
8
45
1.81
0.85
1.3
1.1
—
17.15
—
0
6
6
32
1.90
0.82
1.3
1.6
—
—
—
0
0
6
34
1.79
0.77
1.0
1.1
—
—
—
0
0
25
187
1.38
0.72
16.4
7.9
—
—
—
0
0
146
1363
1.25
0.72
32.9
15.7
36.34
39.73
%
2.71
80
967
15
103
1.49
0.67
2.7
2.1
8.01
12.09
nmol/l
—
10
95
8
50
1.62
0.62
2.4
1.5
—
—
—
0
0
0
22
0.00
0.59
0.0
4.3
—
—
—
0
0
6
38
1.60
0.55
2.2
1.8
—
—
—
0
0
5
32
1.58
0.42
1.0
1.2
—
—
—
0
0
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
5
34
1.48
0.40
1.4
1.2
411.20
189.23
e6/l
—
5
26
5
34
1.48
0.40
1.2
1.4
—
—
—
0
0
5
37
1.36
0.37
1.2
1.4
—
—
—
0
0
5
37
1.36
0.37
1.2
1.4
—
—
—
0
0
6
86
0.69
0.34
2.8
2.3
—
—
—
0
0
7
52
1.36
0.31
1.3
1.2
—
—
—
0
0
7
53
1.33
0.31
1.3
1.2
—
—
—
0
0
23
196
1.20
0.28
1.3
1.4
—
—
—
0
0
43
391
1.13
0.24
1.6
1.6
1.38
1.39
mmol/l
0.03
37
320
8
101
0.78
0.21
1.8
1.7
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
22
246
0.88
0.17
2.1
1.4
—
—
—
0
0
17
153
1.12
0.11
2.5
2.3
32.33
29.50
u/l
0.15
12
125
6
75
0.79
0.07
2.3
2.0
—
—
—
0
0
42
403
1.05
0.07
3.8
4.2
17.24
21.27
%
1.13
20
189
8
91
0.87
0.07
1.5
1.4
—
—
—
0
0
29
282
1.03
0.02
2.7
2.6
2.36
0.95
e6/l
0.69
18
163
30
293
1.03
0.01
3.4
2.9
0.80
0.85
ug/l
0.12
24
196
15
151
0.99
0.00
2.2
2.1
—
—
—
0
0
16
163
0.98
0.00
2.2
2.4
—
—
—
0
0
0
5
0.00
0.00
0.0
11.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
6
59
1.02
0.00
1.2
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
5
52
0.96
0.00
2.2
2.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
1327.40
—
0
5
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
0.31
—
0
7
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: VWXY20_SAIRAALO_LIITTYVAT_TAPATURMAT – Nosocomial condition (hospital)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).